ATE364690T1 - Posh nukleinsäure, polypeptide und darauf bezogene verfahren - Google Patents

Posh nukleinsäure, polypeptide und darauf bezogene verfahren

Info

Publication number
ATE364690T1
ATE364690T1 AT02257796T AT02257796T ATE364690T1 AT E364690 T1 ATE364690 T1 AT E364690T1 AT 02257796 T AT02257796 T AT 02257796T AT 02257796 T AT02257796 T AT 02257796T AT E364690 T1 ATE364690 T1 AT E364690T1
Authority
AT
Austria
Prior art keywords
related methods
polypeptides
nucleic acid
posh nucleic
posh
Prior art date
Application number
AT02257796T
Other languages
English (en)
Inventor
Iris Alroy
Shmuel Tuvia
Tsvika Greener
Danny Ben-Avraham
Original Assignee
Proteologics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteologics Inc filed Critical Proteologics Inc
Application granted granted Critical
Publication of ATE364690T1 publication Critical patent/ATE364690T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y603/00—Ligases forming carbon-nitrogen bonds (6.3)
    • C12Y603/02—Acid—amino-acid ligases (peptide synthases)(6.3.2)
    • C12Y603/02019—Ubiquitin-protein ligase (6.3.2.19), i.e. ubiquitin-conjugating enzyme
AT02257796T 2001-11-09 2002-11-11 Posh nukleinsäure, polypeptide und darauf bezogene verfahren ATE364690T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34584601P 2001-11-09 2001-11-09
US36453002P 2002-03-15 2002-03-15

Publications (1)

Publication Number Publication Date
ATE364690T1 true ATE364690T1 (de) 2007-07-15

Family

ID=26994569

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02257796T ATE364690T1 (de) 2001-11-09 2002-11-11 Posh nukleinsäure, polypeptide und darauf bezogene verfahren

Country Status (11)

Country Link
US (4) US7250250B2 (de)
EP (1) EP1310552B1 (de)
JP (1) JP2005519636A (de)
AT (1) ATE364690T1 (de)
AU (1) AU2002365160C1 (de)
CA (1) CA2465973C (de)
DE (1) DE60220621T2 (de)
HK (1) HK1055996A1 (de)
IL (2) IL161764A0 (de)
NZ (1) NZ532908A (de)
WO (1) WO2003095971A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005007141A2 (en) 2003-07-11 2005-01-27 Proteologics, Inc. Ubiquitin ligase inhibitors and methods related thereto
US20060188890A1 (en) * 2003-10-31 2006-08-24 Proteologics, Inc. Ubiquitin-based protein interaction assays and related compositions
AU2005295517A1 (en) * 2004-10-15 2006-04-27 Signal Pharmaceuticals, Llc P27 ubiquitination assay and methods of use
EP2482075A1 (de) 2004-12-01 2012-08-01 Proteologics, Ltd Ubiquitin-Ligase-Assays und verwandte Reagenzien
JP2008092911A (ja) * 2006-10-16 2008-04-24 Univ Of Tokyo タンパク質結合検出方法
CN101688836B (zh) * 2007-08-30 2012-08-29 三井造船株式会社 Fret检测方法及装置
EP3067359A1 (de) 2008-09-23 2016-09-14 Scott G. Petersen Selbstfreisetzende biolabile phosphatgeschützte pro-oligos für therapeutika auf oligonukleotidbasis und vermittlung von rna-interferenz
US9901617B2 (en) * 2013-08-14 2018-02-27 The Curators Of The University Of Missouri Cell permeable inhibitors of the scaffold protein plenty of SH3 domains (POSH) or Sh3Rfl
CN106754883B (zh) * 2016-12-30 2019-10-29 中山大学 一种一步、无缝、非同源、多片段的基因拼接改造方法及其试剂盒
CN112764372A (zh) * 2020-12-25 2021-05-07 天津大学 基于vpx架构的多通道信号采集系统

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000008181A2 (en) * 1998-08-07 2000-02-17 Onyx Pharmaceuticals, Inc. Chp polypeptide, a ligand of pak65
JP2003527824A (ja) * 1998-10-13 2003-09-24 オニックス ファーマシューティカルズ，インコーポレイティド ポリペプチドおよび核酸をシグナリングする新規細胞
WO2000027865A1 (en) 1998-11-06 2000-05-18 The Brigham And Women's Hospital, Inc. CHARACTERIZATION OF NOVEL GENE cbl-SL
EP1074617A3 (de) 1999-07-29 2004-04-21 Research Association for Biotechnology Primers für Synthese von ganzen-Länge cDNS und deren Anwendung
AU7701100A (en) 1999-09-03 2001-04-10 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer
CA2392398A1 (en) 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
AU2001234944A1 (en) 2000-02-03 2001-08-14 Hyseq, Inc. Novel nucleic acids and polypeptides
AU2001241541A1 (en) 2000-02-17 2001-08-27 Millennium Predictive Medicine, Inc. Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of human prostate cancer
AU2001238347A1 (en) 2000-02-28 2001-09-12 Hyseq, Inc. Novel nucleic acids and polypeptides
AU4592601A (en) 2000-03-21 2001-10-03 Millennium Predictive Medicine Novel genes, compositions, kits, and method for identification, assessment, prevention, and therapy of ovarian cancer
AU2001245945A1 (en) 2000-03-23 2001-10-03 Pe Corporation (Ny) Detection kits, such as nucleic acid arrays, for detecting the expression of 10,000 or more drosophila genes and uses thereof
WO2001077288A2 (en) 2000-04-06 2001-10-18 Genetics Institute, Llc. Polynucleotides encoding novel secreted proteins
AU2001263006A1 (en) 2000-05-18 2001-11-26 Hyseq, Inc. Novel nucleic acids and polypeptides
JP2004509629A (ja) 2000-09-19 2004-04-02 ホワイトヘッド　インスチチュート　フォアー　バイオメディカル　リサーチ 腫瘍に対する遺伝子マーカー
EP1629082A4 (de) 2000-10-20 2009-07-22 Univ Massachusetts Mit glucosetransport in zusammenhang stehende gene und deren verwendungen
WO2002057414A2 (en) 2000-10-20 2002-07-25 Expression Diagnostics, Inc. Leukocyte expression profiling
WO2003008647A2 (en) 2000-11-28 2003-01-30 University Of Cincinnati Blood assessment of injury
WO2002077235A2 (en) 2000-12-21 2002-10-03 Incyte Genomics, Inc. Intracellular signaling molecules
WO2002053719A2 (en) * 2001-01-04 2002-07-11 Incyte Genomics, Inc. Cytoskeleton-associated proteins
AU2002245317A1 (en) 2001-01-24 2002-08-06 Protein Design Labs Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
US6743619B1 (en) 2001-01-30 2004-06-01 Nuvelo Nucleic acids and polypeptides
EP1404868A2 (de) 2001-02-28 2004-04-07 Chondrogene Inc. Zusammensetzungen und methoden die sich auf osteoarthritis beziehen
AU2002311787A1 (en) 2001-03-28 2002-10-15 Zycos Inc. Translational profiling
CA2447183A1 (en) * 2001-03-28 2002-10-10 Incyte Genomics, Inc. Molecules for disease detection and treatment
US20030087259A1 (en) 2001-04-18 2003-05-08 Clancy Brian M. Methods and compositions for regulating bone and cartilage formation
WO2002095000A2 (en) 2001-05-22 2002-11-28 Gene Logic, Inc. Molecular toxicology modeling
WO2003022987A2 (en) 2001-07-26 2003-03-20 Eos Biotechnology, Inc. Methods of diagnosis of hepatitis c infection, compositions and methods of screening for modulators of hepatitis c infection
IL160138A0 (en) 2001-07-31 2004-06-20 Proteologics Inc Compositions and methods for modulation of viral maturation
EP1434881A4 (de) 2001-09-17 2005-10-26 Protein Design Labs Inc Verfahren zur diagnose von krebszusammensetzungen und verfahren zum screening auf krebsmodulatoren
WO2003038130A2 (en) 2001-10-31 2003-05-08 Pfizer Products Inc. Therapeutics and diagnostics for disorders of erythropoiesis
US20030175253A1 (en) 2001-11-09 2003-09-18 Huda Akil Compositions and methods for diagnosing and treating mental disorders
US20040096828A1 (en) * 2002-01-04 2004-05-20 Lu Dyung Aina M Cytoskeleton-associated proteins

Also Published As

Publication number Publication date
EP1310552B1 (de) 2007-06-13
US20080187538A1 (en) 2008-08-07
US20040025196A1 (en) 2004-02-05
US7429643B2 (en) 2008-09-30
IL161764A (en) 2010-12-30
DE60220621T2 (de) 2008-03-06
DE60220621D1 (de) 2007-07-26
IL161764A0 (en) 2005-11-20
AU2002365160B2 (en) 2008-10-30
US7268227B2 (en) 2007-09-11
US7250250B2 (en) 2007-07-31
AU2002365160A1 (en) 2003-11-11
EP1310552A2 (de) 2003-05-14
EP1310552A3 (de) 2003-10-08
NZ532908A (en) 2008-04-30
CA2465973C (en) 2013-04-16
AU2002365160C1 (en) 2009-08-13
CA2465973A1 (en) 2003-11-20
HK1055996A1 (en) 2004-01-30
US20060019240A1 (en) 2006-01-26
WO2003095971A2 (en) 2003-11-20
JP2005519636A (ja) 2005-07-07
US20060035213A1 (en) 2006-02-16
WO2003095971A3 (en) 2005-04-28

Similar Documents

Publication Publication Date Title
ATE405647T1 (de) Rekombinantes gelatin in impstoffen
DK1648931T3 (da) Multifunktionelle cytokiner
ATE315088T1 (de) Tumorassoziierte antigenderivate der mage-familie,nukleinsäuresequenzen die dafür kodieren, zur herstellung von fusionsproteinen und zusammensetzungen zur impfung
DE60114525D1 (de) Array-basierende Methoden zur Synthese von Nukleinsäuregemischen
ATE397070T1 (de) Klonierte genome von infektiösen hepatitis c viren und deren verwendungen
DE60032367D1 (de) Aktivierbare rekombinante neurotoxine
ATE392430T1 (de) Verfahren zur herstellung von dipeptiden
DE60010285D1 (de) Verfahren zur Herstellung von Amino-Oxide
ATE364690T1 (de) Posh nukleinsäure, polypeptide und darauf bezogene verfahren
DK1321477T3 (da) Fremgangsmåde til frembringelsen af genetisk modificerede vertebrate precursor-lymfocytter og anvendelse deraf til fremstillingen af heterologe bindende proteiner
NO20073914L (no) Biologisk aktive peptider
DE60231149D1 (de) Zusammensetzungen mit hochgenauer dna-polymerase und verwendungen dafür
EP1558729A4 (de) Schnell abgebaute reporter-fusionsproteine
DE60239842D1 (de) Verfahren zur Herstellung von 10,11-dihydro-10-oxo-5h-dibenzoÄb,fÜazepin-5-carboxamid
ATE506370T1 (de) Reagenzien und verfahren zur bildung von disulfid-bindungen und glykosylierung von proteinen
DE1105508T1 (de) Verfahren zur reinigung von proteinen und biomolekül- oder proteinkomplexen
DE60030726D1 (de) Methode zur Herstellung von Mikropartikeln enthaltend biologisches Material
DE60230097D1 (de) Verfahren zur herstellung von 1,5-diaminonaphthalinen
WO2003060067A3 (en) P85-alpha nucleic acids, polypeptides and related methods
DE69832622D1 (de) Methoden zur durchforstung (screenen) von proteinen
ITRM20010257A0 (it) Procedimento per la rinaturazione, idrolisi e produzione di proteine pr ricombinanti, composizioni e kit utilizzabili in tali procedimenti.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties